• Unexpected and Potentially Extremely Useful Data in Development of mRNA and Small Molecule Immunotherapies for Treating Cancer and Autoimmune Disorders: Regen BioPharma, (OTC-PINK: RGBP) and (OTC-PINK: RGBPP)
BALTIMORE, MD / ACCESSWIRE / October 4, 2023 / Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has published a new research report on Regen BioPharma, Inc. (OTCPK:RGBP). Leveraging its deep IP and surprising results from Phase I of in vitro experiments, Regen may be poised to initiate a Phase I clinical trial in the large autoimmune therapeutic category. The Goldman report carries a price target. To view the new research report, along with disclosures and disclaimers, or to download the report in its entirety, please visit: https://bit.ly/48BJkGG.
SAN FRANCISCO, CA / ACCESSWIRE / February 14, 2022 / Oncology Pharma, Inc. ("The Company") (OTC PINK:ONPH) and Regen BioPharma, Inc. (OTC PINK:RGBP) and (OTC PINK:RGBPP): announced that they intend to work jointly to fast track the development of therapeutic uses related to treatment in humans with pancreatic cancer of Regen's patented ANTIGEN SPECIFIC MRNA CELLULAR CANCER VACCINES ("MRNA Vaccines"). In April of 2021 ONPH was granted an
Reddit has become synonymous with retail traders. The markets have seen much lighter volume this month, overall. Several stocks have begun trending among retail (Reddit) traders
